NYSE: CSRCenterspace Stock
$63.78-0.40 (-0.62%)
Updated Mar 21, 2025
CSR Price
$63.78
Fair Value Price
N/A
Market Cap
$1.07B
52 Week Low
$54.90
52 Week High
$76.16
P/E
-50.22x
P/B
1.63x
P/S
3.93x
PEG
N/A
Dividend Yield
4.7%
Revenue
$260.98M
Earnings
-$11.33M
Gross Margin
56.9%
Operating Margin
9.94%
Profit Margin
-7.5%
Debt to Equity
1.55
Operating Cash Flow
$98M
Beta
0.72
Next Earnings
Apr 28, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CSR Overview
Centerspace is a Real Estate Investment Trust REIT that owns and manages multifamily communities in Colorado, Minnesota, Montana, Nebraska, North Dakota, and South Dakota. As of 2021/06, Centerspace owned 62 apartment buildings. The company was founded on 1970 and is headquartered in Minot, ND.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CSR's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Residential REIT
Industry Rating
F
CSR
Ranked#11 of 19
Ranked#11 of 19
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $33.87 | C | |
| $8.61 | C | |
| $68.47 | C |
Be the first to know about important CSR news, forecast changes, insider trades & much more!
CSR News
Overview
Due Diligence Score
–
Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CSR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CSR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CSR is good value based on its book value relative to its share price (1.63x), compared to the US REIT - Residential industry average (2.6x)
P/B vs Industry Valuation
CSR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more CSR due diligence checks available for Premium users.
Valuation
CSR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-50.22x
Industry
65.91x
Market
31.55x
CSR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.63x
Industry
2.6x
CSR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CSR's financial health
Profit margin
Revenue
$66.4M
Net Income
-$5.1M
Profit Margin
-7.6%
CSR's Earnings (EBIT) of $25.95M... subscribe to Premium to read more.
Interest Coverage Financials
CSR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.9B
Liabilities
$1.0B
Debt to equity
1.55
CSR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CSR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$18.7M
Investing
-$10.3M
Financing
-$12.5M
CSR's operating cash flow ($98.25M)... subscribe to Premium to read more.
Debt Coverage Financials
CSR vs Residential REIT Stocks
Centerspace Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.